<DOC>
	<DOCNO>NCT02068170</DOCNO>
	<brief_summary>A prospective , observational study university hospital ( UZ Leuven ) . Patients include treated potentional QT-prolonging drug : haloperidol delirium , antibiotic ( moxifloxacin , levofloxacin , azithromycin , clarithromycin , erythromycin , co-trimoxazole ) , antimycotic ( ketoconazole , itraconazole , fluconazole , voriconazole ) , methadone , tacrolimus oral oncolytics . An ECG take administration drug 3-5 day start drug investigate change duration QTc-interval . Risk factor develop QT-prolongation document . Together ECG2 , additional blood sample collect measure blood concentration drug .</brief_summary>
	<brief_title>Risk QT-prolongation Torsade de Pointes Patients Treated With Acute Medication University Hospital</brief_title>
	<detailed_description />
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Long QT Syndrome</mesh_term>
	<mesh_term>Torsades de Pointes</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>treatment potentional QTprolonging drug list inpatient UZ Leuven , admit one participating ward &lt; 18 year old DNRcode 3 possible take ECG start haloperidol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>QT-prolongation</keyword>
	<keyword>Torsade de Pointes</keyword>
	<keyword>QT-prolonging drug</keyword>
</DOC>